- Report
- October 2024
- 105 Pages
United States
From €3105EUR$3,500USD£2,710GBP
- Report
- September 2025
- 120 Pages
United States
From €3504EUR$3,950USD£3,059GBP
- Report
- July 2025
- 200 Pages
United States
From €2209EUR$2,490USD£1,928GBP
- Report
- July 2025
- 200 Pages
Europe
From €2209EUR$2,490USD£1,928GBP
- Report
- March 2025
- 200 Pages
United States
From €2209EUR$2,490USD£1,928GBP
- Report
- January 2025
- 120 Pages
United States
From €2209EUR$2,490USD£1,928GBP
- Report
- August 2025
- 121 Pages
United States
From €2262EUR$2,549USD£1,974GBP
€2661EUR$2,999USD£2,322GBP
- Report
- February 2025
- 146 Pages
Middle East
From €2262EUR$2,549USD£1,974GBP
€2661EUR$2,999USD£2,322GBP
- Report
- November 2024
- 85 Pages
United States
From €3105EUR$3,500USD£2,710GBP
- Report
- April 2025
- 170 Pages
Europe
From €3061EUR$3,450USD£2,672GBP
- Report
- April 2025
- 188 Pages
Asia Pacific
From €3061EUR$3,450USD£2,672GBP
- Report
- April 2025
- 158 Pages
North America
From €3061EUR$3,450USD£2,672GBP
- Report
- April 2025
- 167 Pages
Middle East, Africa
From €3061EUR$3,450USD£2,672GBP
- Report
- July 2025
- 250 Pages
Middle East, Africa
From €3433EUR$3,869USD£2,996GBP
- Report
- July 2025
- 250 Pages
Latin America
From €3433EUR$3,869USD£2,996GBP
- Report
- July 2025
- 250 Pages
Asia Pacific
From €3433EUR$3,869USD£2,996GBP
- Report
- July 2025
- 250 Pages
North America
From €3433EUR$3,869USD£2,996GBP
- Report
- July 2025
- 250 Pages
Europe
From €3433EUR$3,869USD£2,996GBP
- Report
- July 2025
- 250 Pages
Latin America
From €3433EUR$3,869USD£2,996GBP
- Report
- July 2025
- 250 Pages
North America
From €3433EUR$3,869USD£2,996GBP

The Infusions and Injectables market is a segment of the pharmaceutical industry that focuses on the production and distribution of drugs that are administered through intravenous (IV) or intramuscular (IM) injections. These drugs are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases. The market is highly competitive, with a number of large pharmaceutical companies vying for market share.
The market is divided into two main segments: branded and generic drugs. Branded drugs are typically more expensive than generic drugs, but they are often more effective and have fewer side effects. Generic drugs are typically cheaper, but they may not be as effective or have as many side effects.
Some of the major players in the Infusions and Injectables market include Pfizer, Merck, Novartis, Sanofi, and Johnson & Johnson. These companies are responsible for the production and distribution of a wide range of drugs, including cancer treatments, diabetes medications, and autoimmune therapies. Show Less Read more